Physician profile
Genell Strobel
NPI 1194728873
$2,778.30
in general payments reported to CMS, 2019-2025
25 companies · $490 in 2025
The $490 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $97.02 · 2021: $170 · 2022: $218 · 2023: $558 · 2024: $756 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.55 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $423.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $536.00 | 2019-2025 | Evenity, Prolia |
| Abbvie INC. | $445.67 | 2023-2024 | Liletta, Botox |
| Allergan, INC. | $317.31 | 2019-2023 | |
| Merz North America, INC. | $251.52 | 2019 | |
| Astellas Pharma US INC | $154.06 | 2023-2025 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $142.56 | 2021-2024 | Verquvo |
| Organon LLC | $133.49 | 2021-2025 | Nexplanon |
| Janssen Pharmaceuticals, INC | $124.99 | 2019 | |
| Radius Health, INC. | $108.15 | 2019-2025 | Tymlos |
| Hologic Sales and Service, LLC | $89.07 | 2019-2024 | Aptima |
| Astrazeneca Pharmaceuticals LP | $84.84 | 2021 | |
| Exeltis, USA INC. | $66.14 | 2024-2025 | Slynd |
| Medicomp INC | $55.09 | 2025 | Telepatch Cardiac Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $38.91 | 2019-2022 | |
| Exact Sciences Corporation | $36.76 | 2023-2024 | Cologuard Collection Kit |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $34.17 | 2025 | Teriparatide |
| Cvrx, INC. | $31.37 | 2024 | Barostim Neo System |
| Glaxosmithkline, LLC. | $20.27 | 2023 | Bexsero |
| Alvogen INC | $19.06 | 2025 | Teriparatide |
| Scpharmaceuticals INC. | $18.61 | 2024 | |
| Acella Pharmaceuticals, LLC | $15.59 | 2023 | NP Thyroid 60 |
| Mayne Pharma Commercial LLC | $13.96 | 2025 | |
| Ascend Therapeutics US, LLC | $13.88 | 2024 | |
| Minerva Surgical, INC | $13.84 | 2023 | |
| Shire North American Group INC | $12.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Genell Strobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.